{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:48:09Z","timestamp":1791820089180,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05613-w","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:16:36Z","timestamp":1784222196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An immunogenic cell death-based signature predicts prognosis and immune landscape in triple-negative breast cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"5613_CR1","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. https:\/\/doi.org\/10.1016\/j.intimp.2020.106535.","journal-title":"Int Immunopharmacol"},{"key":"5613_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","volume":"497","author":"X Bai","year":"2021","unstructured":"Bai X, Ni J, Beretov J, Graham P, Li Y. Triple-negative breast cancer therapeutic resistance: Where is the Achilles\u2019 heel? Cancer Lett. 2021;497:100\u201311. https:\/\/doi.org\/10.1016\/j.canlet.2020.10.016.","journal-title":"Cancer Lett"},{"key":"5613_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2021.06.015","volume":"82","author":"Z Hua","year":"2022","unstructured":"Hua Z, White J, Zhou J. Cancer stem cells in TNBC. Semin Cancer Biol. 2022;82:26\u201334. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.015.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"5613_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","volume":"17","author":"Z Wang","year":"2020","unstructured":"Wang Z, Jiang Q, Dong C. Metabolic reprogramming in triple-negative breast cancer. Cancer Biol Med. 2020;17(1):44\u201359. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0210.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"5613_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer. 2022;8(1):95. https:\/\/doi.org\/10.1038\/s41523-022-00468-0.","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"5613_CR6","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994\u20133006. https:\/\/doi.org\/10.1002\/1878-0261.12851.","journal-title":"Mol Oncol"},{"issue":"6","key":"5613_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/13543784.2022.2049232","volume":"31","author":"E Agostinetto","year":"2022","unstructured":"Agostinetto E, Losurdo A, Nader-Marta G, et al. Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert Opin Investig Drugs. 2022;31(6):567\u201391. https:\/\/doi.org\/10.1080\/13543784.2022.2049232.","journal-title":"Expert Opin Investig Drugs"},{"key":"5613_CR8","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak KGK, Vempati R, Nagaraju GP, et al. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683. https:\/\/doi.org\/10.1016\/j.phrs.2020.104683.","journal-title":"Pharmacol Res"},{"issue":"1","key":"5613_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol OncolJ Hematol Oncol. 2023;16(1):100. https:\/\/doi.org\/10.1186\/s13045-023-01497-3.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"1","key":"5613_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hu Y, Xue J, et al. Advances in immunotherapy for triple-negative breast cancer. Mol Cancer. 2023;22(1):145. https:\/\/doi.org\/10.1186\/s12943-023-01850-7.","journal-title":"Mol Cancer"},{"key":"5613_CR11","doi-asserted-by":"publisher","first-page":"919072","DOI":"10.3389\/fonc.2022.919072","volume":"12","author":"C Luo","year":"2022","unstructured":"Luo C, Wang P, He S, Zhu J, Shi Y, Wang J. Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer. Front Oncol. 2022;12:919072. https:\/\/doi.org\/10.3389\/fonc.2022.919072.","journal-title":"Front Oncol"},{"issue":"4","key":"5613_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500. https:\/\/doi.org\/10.1038\/s41590-022-01132-2.","journal-title":"Nat Immunol"},{"key":"5613_CR13","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"Castro-Vega LJ, Letouz\u00e9 E, Burnichon N, et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat Commun. 2015;6:6044. https:\/\/doi.org\/10.1038\/ncomms7044.","journal-title":"Nat Commun"},{"key":"5613_CR14","doi-asserted-by":"publisher","first-page":"986214","DOI":"10.3389\/fimmu.2022.986214","volume":"13","author":"JY Liu","year":"2022","unstructured":"Liu JY, Liu LP, Li Z, Luo YW, Liang F. The role of cuproptosis-related gene in the classification and prognosis of melanoma. Front Immunol. 2022;13:986214. https:\/\/doi.org\/10.3389\/fimmu.2022.986214.","journal-title":"Front Immunol"},{"issue":"21","key":"5613_CR15","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1073\/pnas.1902375116","volume":"116","author":"S Horibata","year":"2019","unstructured":"Horibata S, Gui G, Lack J, DeStefano CB, Gottesman MM, Hourigan CS. Heterogeneity in refractory acute myeloid leukemia. Proc Natl Acad Sci U S A. 2019;116(21):10494\u2013503. https:\/\/doi.org\/10.1073\/pnas.1902375116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5613_CR16","doi-asserted-by":"publisher","first-page":"103314","DOI":"10.1016\/j.autrev.2023.103314","volume":"22","author":"S Keret","year":"2023","unstructured":"Keret S, Rimar D, Lansiaux P, et al. Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians. Autoimmun Rev. 2023;22(6):103314. https:\/\/doi.org\/10.1016\/j.autrev.2023.103314.","journal-title":"Autoimmun Rev"},{"key":"5613_CR17","doi-asserted-by":"publisher","first-page":"803355","DOI":"10.3389\/fimmu.2022.803355","volume":"13","author":"H Lu","year":"2022","unstructured":"Lu H, Wu J, Liang L, Wang X, Cai H. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Front Immunol. 2022;13:803355. https:\/\/doi.org\/10.3389\/fimmu.2022.803355.","journal-title":"Front Immunol"},{"key":"5613_CR18","doi-asserted-by":"publisher","first-page":"106597","DOI":"10.1016\/j.compbiomed.2023.106597","volume":"154","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhu H, Wang X, Lin S, Ruan C, Wang Q. A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas. Comput Biol Med. 2023;154:106597. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106597.","journal-title":"Comput Biol Med"},{"issue":"1","key":"5613_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12575-021-00152-w","volume":"23","author":"ZL Yu","year":"2021","unstructured":"Yu ZL, Zhu ZM. N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer. Biol Proced Online. 2021;23(1):15. https:\/\/doi.org\/10.1186\/s12575-021-00152-w.","journal-title":"Biol Proced Online"},{"issue":"1","key":"5613_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12885-022-09377-8","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhu GQ, Tian D, et al. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. BMC Cancer. 2022;22(1):316. https:\/\/doi.org\/10.1186\/s12885-022-09377-8.","journal-title":"BMC Cancer"},{"issue":"5","key":"5613_CR21","doi-asserted-by":"publisher","first-page":"e005980","DOI":"10.1136\/jitc-2022-005980","volume":"11","author":"L Zeng","year":"2023","unstructured":"Zeng L, Xu H, Li SH, et al. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. J Immunother Cancer. 2023;11(5):e005980. https:\/\/doi.org\/10.1136\/jitc-2022-005980.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5613_CR22","doi-asserted-by":"publisher","first-page":"14866","DOI":"10.1038\/s41598-023-41713-1","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Q, Hu C, Zhang Z, She J, Shi F. Real-world analysis of survival benefit of surgery and adjuvant therapy in elderly patients with colorectal cancer. Sci Rep. 2023;13(1):14866. https:\/\/doi.org\/10.1038\/s41598-023-41713-1.","journal-title":"Sci Rep"},{"key":"5613_CR23","doi-asserted-by":"publisher","first-page":"636614","DOI":"10.3389\/fimmu.2021.636614","volume":"12","author":"S Lu","year":"2021","unstructured":"Lu S, Cai S, Peng X, Cheng R, Zhang Y. Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma. Front Immunol. 2021;12:636614. https:\/\/doi.org\/10.3389\/fimmu.2021.636614.","journal-title":"Front Immunol"},{"key":"5613_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neunet.2022.05.005","volume":"152","author":"P Li","year":"2022","unstructured":"Li P, Zhang W, Lu C, Zhang R, Li X. Robust kernel principal component analysis with optimal mean. Neural Netw Off J Int Neural Netw Soc. 2022;152:347\u201352. https:\/\/doi.org\/10.1016\/j.neunet.2022.05.005.","journal-title":"Neural Netw Off J Int Neural Netw Soc"},{"key":"5613_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neunet.2019.05.020","volume":"118","author":"JX Mi","year":"2019","unstructured":"Mi JX, Zhang YN, Lai Z, Li W, Zhou L, Zhong F. Principal Component Analysis based on Nuclear norm Minimization. Neural Netw Off J Int Neural Netw Soc. 2019;118:1\u201316. https:\/\/doi.org\/10.1016\/j.neunet.2019.05.020.","journal-title":"Neural Netw Off J Int Neural Netw Soc"},{"key":"5613_CR26","doi-asserted-by":"publisher","first-page":"1171811","DOI":"10.3389\/fimmu.2023.1171811","volume":"14","author":"Y Guo","year":"2023","unstructured":"Guo Y, Wu Z, Cen K, et al. Establishment and validation of a ubiquitination-related gene signature associated with prognosis in pancreatic duct adenocarcinoma. Front Immunol. 2023;14:1171811. https:\/\/doi.org\/10.3389\/fimmu.2023.1171811.","journal-title":"Front Immunol"},{"key":"5613_CR27","doi-asserted-by":"publisher","first-page":"1096608","DOI":"10.3389\/fonc.2022.1096608","volume":"12","author":"J Cao","year":"2022","unstructured":"Cao J, Hong K, Cao Y, et al. Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients. Front Oncol. 2022;12:1096608. https:\/\/doi.org\/10.3389\/fonc.2022.1096608.","journal-title":"Front Oncol"},{"key":"5613_CR28","doi-asserted-by":"publisher","first-page":"922195","DOI":"10.3389\/fimmu.2022.922195","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Feng Y, Yan F, Zhao Y, Zhao H, Guo Y. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study. Front Immunol. 2022;13:922195. https:\/\/doi.org\/10.3389\/fimmu.2022.922195.","journal-title":"Front Immunol"},{"issue":"17","key":"5613_CR29","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1200\/JCO.21.02010","volume":"40","author":"S Park","year":"2022","unstructured":"Park S, Ock CY, Kim H, et al. Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2022;40(17):1916\u201328. https:\/\/doi.org\/10.1200\/JCO.21.02010.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5613_CR30","doi-asserted-by":"publisher","first-page":"843408","DOI":"10.3389\/fimmu.2022.843408","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang T, Dai L, Shen S, et al. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. Front Immunol. 2022;13:843408. https:\/\/doi.org\/10.3389\/fimmu.2022.843408.","journal-title":"Front Immunol"},{"issue":"1","key":"5613_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","volume":"19","author":"X Zhao","year":"2021","unstructured":"Zhao X, Zhang L, Wang J, et al. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35. https:\/\/doi.org\/10.1186\/s12967-020-02698-x.","journal-title":"J Transl Med"},{"key":"5613_CR32","doi-asserted-by":"publisher","first-page":"1030198","DOI":"10.3389\/fimmu.2023.1030198","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chao P, Zhang L, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198. https:\/\/doi.org\/10.3389\/fimmu.2023.1030198.","journal-title":"Front Immunol"},{"issue":"1","key":"5613_CR33","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12967-023-04350-w","volume":"21","author":"M Yan","year":"2023","unstructured":"Yan M, Li W, Wei R, et al. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy. J Transl Med. 2023;21(1):490. https:\/\/doi.org\/10.1186\/s12967-023-04350-w.","journal-title":"J Transl Med"},{"issue":"1","key":"5613_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21505594.2017.1313372","volume":"9","author":"R Roy","year":"2018","unstructured":"Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522\u201354. https:\/\/doi.org\/10.1080\/21505594.2017.1313372.","journal-title":"Virulence"},{"key":"5613_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jare.2023.02.005","volume":"54","author":"H Kumar","year":"2023","unstructured":"Kumar H, Gupta NV, Jain R, et al. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer. J Adv Res. 2023;54:271\u201392. https:\/\/doi.org\/10.1016\/j.jare.2023.02.005.","journal-title":"J Adv Res"},{"issue":"7","key":"5613_CR36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/hepr.12414","volume":"45","author":"KK Kuo","year":"2015","unstructured":"Kuo KK, Jian SF, Li YJ, et al. Epigenetic inactivation of transforming growth factor-\u03b21 target gene HEYL, a novel tumor suppressor, is involved in the P53-induced apoptotic pathway in hepatocellular carcinoma. Hepatol Res Off J Jpn Soc Hepatol. 2015;45(7):782\u201393. https:\/\/doi.org\/10.1111\/hepr.12414.","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"2","key":"5613_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41419-023-05674-7","volume":"14","author":"S Brahim","year":"2023","unstructured":"Brahim S, Negulescu AM, Geneste C, et al. Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer. Cell Death Dis. 2023;14(2):171. https:\/\/doi.org\/10.1038\/s41419-023-05674-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5613_CR38","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1186\/s12885-019-6396-4","volume":"19","author":"S Weber","year":"2019","unstructured":"Weber S, Koschade SE, Hoffmann CM, et al. The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. BMC Cancer. 2019;19(1):1181. https:\/\/doi.org\/10.1186\/s12885-019-6396-4.","journal-title":"BMC Cancer"},{"issue":"5","key":"5613_CR39","doi-asserted-by":"publisher","first-page":"188799","DOI":"10.1016\/j.bbcan.2022.188799","volume":"1877","author":"B Wang","year":"2022","unstructured":"Wang B, Wang M, Ao D, Wei X. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Biochim Biophys Acta Rev Cancer. 2022;1877(5):188799. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188799.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"11","key":"5613_CR40","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cac2.12361","volume":"42","author":"E Verdugo","year":"2022","unstructured":"Verdugo E, Puerto I, Medina M\u00c1. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. Cancer Commun Lond Engl. 2022;42(11):1083\u2013111. https:\/\/doi.org\/10.1002\/cac2.12361.","journal-title":"Cancer Commun Lond Engl"},{"issue":"4","key":"5613_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3892\/ijo.2024.5622","volume":"64","author":"W Zhang","year":"2024","unstructured":"Zhang W, Tang X, Peng Y, Xu Y, Liu L, Liu S. GBP2 enhances paclitaxel sensitivity in triple\u2013negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K\/AKT\/mTOR pathway. Int J Oncol. 2024;64(4):34. https:\/\/doi.org\/10.3892\/ijo.2024.5622.","journal-title":"Int J Oncol"},{"key":"5613_CR42","doi-asserted-by":"publisher","first-page":"915246","DOI":"10.3389\/fimmu.2022.915246","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Yang G. IL22RA1\/JAK\/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis. Front Immunol. 2022;13:915246. https:\/\/doi.org\/10.3389\/fimmu.2022.915246.","journal-title":"Front Immunol"},{"issue":"4","key":"5613_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov. 2021;11(4):933\u201359. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1808.","journal-title":"Cancer Discov"},{"key":"5613_CR44","doi-asserted-by":"publisher","first-page":"121425","DOI":"10.1016\/j.biomaterials.2022.121425","volume":"282","author":"R Guo","year":"2022","unstructured":"Guo R, Wang S, Zhao L, et al. Engineered nanomaterials for synergistic photo-immunotherapy. Biomaterials. 2022;282:121425. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121425.","journal-title":"Biomaterials"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05613-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:04:18Z","timestamp":1791817458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05613-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5613"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05613-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were approved by the Animal Ethics Committee of Tianjin Medical University, and all experimental operations were conducted in compliance with the *Guidelines for Ethical Review of Animal Welfare in Experimental Animals in China* and the requirements of the Animal Ethics Committee of Tianjin Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not application.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1424"}}